Grunenthal keep their money in their pockets and will only incur...

  1. 8,875 Posts.
    lightbulb Created with Sketch. 1465
    Grunenthal keep their money in their pockets and will only incur costs after MSB shareholders pay for FDA approval for CLBP.

    I didn't realise you were a Grunenthal shareholder. You are rightfully happy.

    If you are only a Mesoblast shareholder, not so much.

    He's given away Europe and Latin America to save his own reputation.



    Do you reckon others may be interested in Europe and Latin America AFTER FDA approval for CLBP?

    But, it will go to them, contractually. What a deal maker.

    I'm happy, if you're happy.
    Last edited by Pledge: 06/06/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$2.45
Change
-0.040(1.61%)
Mkt cap ! $3.135B
Open High Low Value Volume
$2.47 $2.47 $2.34 $9.610M 3.975M

Buyers (Bids)

No. Vol. Price($)
1 500 $2.44
 

Sellers (Offers)

Price($) Vol. No.
$2.45 30998 2
View Market Depth
Last trade - 16.10pm 30/07/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.